Phase I/II Study for Patients With Newly Diagnosed Glioblastoma Testing Nelfinavir in Combination With Concomitant Temozolomide and Radiotherapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Nelfinavir (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 10 Apr 2015 Biomarkers information updated
- 24 Jan 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 24 Jan 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.